Ashwagandha has become one of the most heavily marketed adaptogens for sleep and stress, appearing in everything from gummies to powders to "calm" blends. A 2025 randomized controlled trial published in the journal Clocks & Sleep put a specific, testable question to it: how does ashwagandha actually compare to melatonin — the more established, better-studied sleep supplement — and does combining the two outperform either alone?
The three-way comparison
The trial tested three approaches head-to-head: ashwagandha alone, melatonin alone, and the two combined. This design matters, because most ashwagandha marketing implies it's a sleep solution on its own, without ever benchmarking it against the supplement with the more established evidence base for sleep specifically.
What the study actually found
- Ashwagandha alone produced a modest but real improvement in sleep quality — most reliably at doses around 600mg/day, taken consistently for 8 or more weeks. This isn't nothing, but it's a slower, gentler effect than many marketing claims suggest.
- Melatonin alone outperformed ashwagandha alone specifically for sleep outcomes — melatonin remains the more directly effective single option when sleep itself is the target.
- The combination of both produced the strongest results of the three arms, suggesting the two may work through complementary mechanisms rather than simply duplicating each other's effect.
Context: how solid is ashwagandha's evidence base overall?
Broader systematic reviews of ashwagandha research describe the overall evidence as real but still "limited and inconsistent" — study quality, dosing, and duration vary considerably across the existing literature, which is a common limitation for herbal/adaptogenic supplements compared to more standardized options like melatonin. This doesn't mean the effect isn't real; it means the evidence base hasn't yet reached the consistency and volume of, say, the vitamin D pregnancy research discussed elsewhere on this site.
Ashwagandha's broader reputation also includes anti-inflammatory and general stress-adaptogenic effects, which are plausible mechanistically but have thinner direct evidence than the sleep-specific findings above.
The honest, practical summary
If sleep specifically is your goal: ashwagandha alone may help modestly, particularly with consistent use over 8+ weeks. Melatonin alone is the more proven single option for sleep. The combination showed the best results in this particular trial — though that's one study, not yet a broad consensus. As with any supplement affecting sleep or hormonal signaling, it's worth discussing with a doctor before starting, especially if you're already taking other sleep aids or have a thyroid condition (ashwagandha can affect thyroid hormone levels in some people).
Why dosing consistency matters more than most people assume
A detail easy to lose in headline summaries: the ashwagandha benefit in this study was tied to consistent daily use over an 8-week-or-longer period, not occasional or as-needed use. This is a meaningful difference from how many people actually use sleep supplements — often reaching for something only on nights sleep already feels difficult, which is closer to how melatonin (a more acute-acting supplement) is typically used, but not how ashwagandha's more gradual mechanism appears to work. Taking it inconsistently likely explains at least some of the "it didn't work for me" anecdotal reports that don't match the trial data.
What "adaptogen" actually claims, and what's tested
Ashwagandha is frequently marketed under the broader "adaptogen" category — a term describing substances claimed to help the body handle physical or psychological stress more effectively. This is a plausible-sounding but harder-to-directly-test concept than a specific outcome like "sleep quality score," which is part of why sleep-specific trials like this one are more useful for evaluation than the broader adaptogen framing alone. When assessing any adaptogen claim, it's worth checking whether a study measured a specific, defined outcome, or simply reported general subjective wellbeing.
Source: 2025 randomized controlled trial published in Clocks & Sleep comparing ashwagandha, melatonin, and combination supplementation for sleep quality outcomes.